Statement on compulsory licences for coronavirus vaccine production
Coronavirus vaccine production needs to be ramped up quickly to ensure global supplies as soon as possible.
BIO Deutschland names important success factors for vaccine production
German biotechnology companies have not only developed coronavirus vaccines, they are also an integral part of the manufacturing process for these vaccines.
BIO Deutschland welcomes EFI Commission’s call to promote CRISPR/Cas
In its new annual report, the Commission of Experts for Research and Innovation (EFI) has emphasised the potential of the CRISPR/Cas gene scissors for medicine.